Sponsored By:
| Dow | 10,318.16 | -14.28 |
| NASDAQ | 2,146.04 | -10.78 |
| S&P | 1,091.38 | -3.52 |
- ChangeWave Investing
- Inner Circle
- Microcap Investor
- ChangeWave Shorts
- Options Trader
- WaveWire
- Options Insider
- ChangeWave Alliance
- Trading Center
- Institutional Investors
- The Alliance
- ChangeQuakes
- Events & Appearances
- Special Reports
- FAQ
- Glossary
- About the Advisers
November 21, 2009
ChangeQuakes Of The Week
February 12, 2007TOP CHANGEQUAKES OF THE WEEK
** Intel Builds Fastest Chip Ever
** G-7 Recommends Vigilance On Hedge Funds
** Climate Challenge Will Heat Up Global Economy, Barclays Predicts
** FDA OKs First Over-The-Counter Weight-Loss Drug
TOP CHANGEQUAKES OF THE WEEK
Intel Builds Fastest Chip Ever
(TECHNOLOGICAL CHANGEQUAKE) -- Capable of processing 1 trillion calculations a second, Intel's latest test chip, when used commercially, will revolutionize computing.
www.businessweek.com
RELATED ARTICLE:
Computers About To Take Quantum Leap Into The Future guardian.co.uk
G-7 Recommends Vigilance On Hedge Funds
(REGULATORY CHANGEQUAKE) -- Finance ministers from the world's leading economies put the $1.4 trillion hedge fund industry firmly on the international policy agenda, saying that they would scrutinize the sector closely with an eye toward encouraging more self-regulation.
www.ith.com
Climate Challenge Will Heat Up Global Economy, Barclays Predicts
(ECONOMIC CHANGEQUAKE) -- In a new report, Barclays Capital challenges the conventional wisdom that global warming will have a devastating impact on economic growth. It believes the need to increase energy capacity by 50 % by 2035, while simultaneously reducing dependence on hydrocarbons, will spark an "energy revolution" reminiscent of the technology revolution that led to the dot-com boom.
independent.co.uk
FDA OKs First Over-The-Counter Weight-Loss Drug
(MEDICAL CHANGEQUAKE) -- The first nonprescription drug to treat obesity in American adults was approved by the FDA. According to manufacturer GlaxoSmithKline, the drug, called alli (orlistat), helps people lose 50% more weight than dieting alone, should cost consumers $12 to $25 a week, and is expected to be available by this summer.
health.discovery.com


